Description
lenalid 25mg (Lenalidomide) has been used to successfully treat both inflammatory disorders and cancers in the past 15 years. Multiple Myeloma and mantle cell lymphoma: 25 mg/day on days 1 through 21 of repeated 28 day cycles. Myelodysplastic Diseases:
Event Details
This information is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals.lenalid 25mg is 50,000 times more potent than thalidomide in inhibiting tumor necrosis factor-alpha, and has less severe adverse drug reactions.